SILAC kinase screen identifies potential MASTL substrates

Kamila A Marzec1, Samuel Rogers2, Rachael McCloy3

  • 1ANZAC Research Institute, Concord Hospital, Concord, NSW, 2139, Australia.

Scientific Reports
|June 22, 2022
PubMed

Insights

Microtubule-associated serine/threonine kinase-like (MASTL) may phosphorylate new substrates beyond Arpp-19/ENSA. This kinase

Area of Science:

  • Cell Biology
  • Biochemistry
  • Oncology

Background:

  • Microtubule-associated serine/threonine kinase-like (MASTL) is a key regulator of mitosis.
  • MASTL is implicated as an oncogene in various cancers.
  • Currently, Arpp-19/ENSA are the sole identified substrates of MASTL.

Purpose of the Study:

  • To identify novel substrates of MASTL.
  • To determine the optimal consensus motif for MASTL activity.
  • To understand MASTL's expanding biological roles in cancer.

Main Methods:

  • Utilized a whole cell lysate in vitro kinase screen.
  • Employed stable isotope labeling with amino acids in cell culture (SILAC) for substrate identification.
  • Validated potential substrates using subsequent in vitro kinase assays.

Main Results:

  • Identified 59 phospho-sites on 67 proteins regulated by active MASTL.
  • The kinase screen, validated with AKT1/2, identified known and novel substrates.
  • hnRNPM, YB1, and TUBA1C were suggested as potential MASTL substrates in vitro.

Conclusions:

  • MASTL likely phosphorylates additional substrates beyond Arpp-19/ENSA.
  • These findings offer insights into MASTL's role in cancer progression and therapy resistance.
  • Further research into MASTL substrates is crucial for developing targeted cancer therapies.